Oncology
2 drugs are in development for Glioblastoma Multiforme.
- Companies
- 2
- Clinical trials
- 29
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Glioblastoma Multiforme pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| TPI 287 | CNS Pharmaceuticals, Inc. (CNSP) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| vbi-1901 | VBI VACCINES INC/BC (VBIV) |
About this indication
Glioblastoma Multiforme context
Oncology·MeSH: Glioblastoma (D005909)
Narrower concept of MeSH descriptor Glioblastoma
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
Frequently asked questions
How many drugs are in development for Glioblastoma Multiforme?
BioSniper tracks 2 drugs in development for Glioblastoma Multiforme across 2 companies.
How many clinical trials target Glioblastoma Multiforme?
There are 29 clinical trials targeting Glioblastoma Multiforme tracked by BioSniper.
What is the prevalence of Glioblastoma Multiforme?
The estimated prevalence of Glioblastoma Multiforme is approximately 3.2 per 100,000 population.